These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 18512854)

  • 21. [Cross-validation of the first trimester screening algorithm of the FMF London on 38,700 pregnancies in Germany].
    Lüthgens K; Abele H; Alkier R; Hoopmann M; Kagan KO
    Ultraschall Med; 2011 Aug; 32(4):367-72. PubMed ID: 21667432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21.
    Kagan KO; Hoopmann M; Baker A; Huebner M; Abele H; Wright D
    Ultrasound Obstet Gynecol; 2012 Aug; 40(2):135-9. PubMed ID: 22262465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
    Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontomaxillary facial angle measurement in screening for trisomy 18 at 11 + 0 to 13 + 6 weeks of pregnancy: a double-centre study.
    Czuba B; Cnota W; Wloch A; Wegrzyn P; Sodowski K; Wielgos M; Borowski D
    Biomed Res Int; 2013; 2013():168302. PubMed ID: 24195065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frontomaxillary facial angle at 11 + 0 to 13 + 6 weeks in Chinese population.
    Chen M; Wang HF; Leung TY; Sahota DS; Borenstein M; Nicolaides K; Lao TT; Lau TK
    J Matern Fetal Neonatal Med; 2011 Mar; 24(3):498-501. PubMed ID: 20593975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P; Rodríguez I; Comas C; Puerto B
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
    Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy.
    Ziolkowska K; Dydowicz P; Sobkowski M; Tobola-Wrobel K; Wysocka E; Pietryga M
    Ginekol Pol; 2019; 90(3):161-166. PubMed ID: 30950006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
    Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first trimester combined test for aneuploidies - a single center experience.
    Veduta A; Vayna AM; Duta S; Panaitescu A; Popescu F; Bari M; Peltecu G; Nedelea F
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2091-2096. PubMed ID: 28553771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.
    Avgidou K; Papageorghiou A; Bindra R; Spencer K; Nicolaides KH
    Am J Obstet Gynecol; 2005 Jun; 192(6):1761-7. PubMed ID: 15970804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women.
    Wøjdemann KR; Shalmi AC; Christiansen M; Larsen SO; Sundberg K; Brocks V; Bang J; Nørgaard-Pedersen B; Tabor A
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):227-33. PubMed ID: 15736185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
    Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of triploidy at 11-14 weeks' gestation: a cohort study of 198 000 pregnant women.
    Engelbrechtsen L; Brøndum-Nielsen K; Ekelund C; Tabor A; Skibsted L;
    Ultrasound Obstet Gynecol; 2013 Nov; 42(5):530-5. PubMed ID: 23494847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.